Brazilian Trials of Sinovac’s COVID-19 Vaccine Are Promising

September 17, 2020

Brazilian Trials of Sinovac’s COVID-19 Vaccine Are Promising

Phase III trials of a COVID-19 vaccine developed by China's Sinovac Biotech Ltd have thus far demonstrated promising results, with the vaccine potentially available commercially by December. According to Sao Paulo’s Governor Joao Doria, 98 percent of elderly people dosed generated an immune response. Approximately 9,000 people are participating in the trial. Yourway has a local depot located in Sao Paulo with over 10,000 square feet of capacity with storage temperatures of up to -20 degrees Celsius.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Schedule a Meeting

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Schedule a Meeting

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat

Hello! How can I help you?